Shockwave Medical
Shockwave Medical, part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
The Principles of Shockwave IVL & its Unique Mechanism of Action by Dr. Ziad A. Ali
The Principles of IVL & its unique Mechanism of Action by Ziad A. Ali, MD, DPhil. Presented at EuroPCR 2021 in the Shockwave IVL Rising Wave Symposium. Coronary IVL Important Safety Information: https://shockwavemedical.com/important-safety-information-coronary-us/
